A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
Clinical trial NCT06398808 · COMPLETED
Trial details
- NCT number
- NCT06398808
- Sponsor
- Zydus Lifesciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2024-11-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.